PTCB Updated PTCE Exam Questions and Answers by angel

Pharmacy staff should always visually inspect nonsterile compounds for signs of incompatibility to ensure medication safety and efficacy. The presence ofprecipitationis a key indicator of an incompatibility issue in nonsterile compounded preparations. Precipitation occurs when a solute (drug) comes out of solution, forming visible solid particles. This can result from changes in pH, solvent composition, or chemical interactions between ingredients.

A. Photolysis:

Decomposition of a drug due to light exposure, leading to color changes or potency loss, but it is not a physical incompatibility visible as precipitation.

B. Hydrolysis:

Chemical breakdown of a drug due to water, common in ester and amide-containing drugs, but not a visual incompatibility like precipitation.

D. Oxidation-Reduction:

A chemical reaction that may change drug color or effectiveness but does not typically lead to visible precipitation in nonsterile compounds.

Other Answer Choices Explained:References:

USP <795> Pharmaceutical Compounding—Nonsterile Preparations

PTCB PTCE Exam Content Outline (Medication Safety & Quality Assurance)

Remington: The Science and Practice of Pharmacy

Per the FDA-approved labeling for NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), the product should be stored refrigerated at 2°C to 8°C (36°F to 46°F) prior to dispensing. After dispensing, NuvaRing may be stored at room temperature for a limited period per labeling (commonly referenced in technician materials as up to 4 months), but pharmacy stock should be kept refrigerated before it is dispensed. Freezing is not recommended.

References (Pharmacy Technician documents/Study Guides):

• NuvaRing Prescribing Information: Storage conditions (refrigeration prior to dispensing; room temperature allowance after dispensing).

• PTCB Top 200/Storage Requirements: Hormonal contraceptive ring storage.

• ASHP/Institutional storage guidelines for temperature-sensitive medications.

1 pint =473 mL(since 1 pint = 16 fluid ounces, and 1 fluid ounce = 29.5735 mL).A1% suspensionmeans1 g (1000 mg) of rifampin per 100 mLof suspension.

Total dose required:2 tbsp daily =30 mL per day(1 tbsp = 15 mL).

Total volume of the suspension:473 mL

Total rifampin required:(473 mL × 1000 mg) ÷ 100 mL =4730 mg

Each rifampin capsule contains300 mg.So,4730 mg ÷ 300 mg/capsule = 15.77 capsules, which rounds up to16 capsules.

Thus, the correct answer isC. 32 capsules(since the full pint must be compounded).

????Reference:Pharmacy compounding principles; PTCE study materials on dosage calculations.

????Reference:USP <797> Sterile Compounding Guidelines.